NO934323L - Medetomidin-preparater for transdermal administrasjon - Google Patents

Medetomidin-preparater for transdermal administrasjon

Info

Publication number
NO934323L
NO934323L NO934323A NO934323A NO934323L NO 934323 L NO934323 L NO 934323L NO 934323 A NO934323 A NO 934323A NO 934323 A NO934323 A NO 934323A NO 934323 L NO934323 L NO 934323L
Authority
NO
Norway
Prior art keywords
medetomidine
transdermal administration
preparations
salts
adhesive layer
Prior art date
Application number
NO934323A
Other languages
English (en)
Other versions
NO303818B1 (no
NO934323D0 (no
Inventor
Harry Jalonen
Arto Karjalainen
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of NO934323L publication Critical patent/NO934323L/no
Publication of NO934323D0 publication Critical patent/NO934323D0/no
Publication of NO303818B1 publication Critical patent/NO303818B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO934323A 1991-05-31 1993-11-29 Medetomidin-preparater for transdermal administrasjon NO303818B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919111732A GB9111732D0 (en) 1991-05-31 1991-05-31 The use of certain salts of medetomidine and its optically active enantiomers to regulate the rate of transdermal administration of the drugs
PCT/FI1992/000167 WO1992021338A1 (en) 1991-05-31 1992-05-27 Medetomidine preparations for transdermal administration

Publications (3)

Publication Number Publication Date
NO934323L true NO934323L (no) 1993-11-29
NO934323D0 NO934323D0 (no) 1993-11-29
NO303818B1 NO303818B1 (no) 1998-09-07

Family

ID=10695876

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934323A NO303818B1 (no) 1991-05-31 1993-11-29 Medetomidin-preparater for transdermal administrasjon

Country Status (17)

Country Link
US (1) US5438067A (no)
EP (1) EP0587819B1 (no)
JP (2) JP3483881B2 (no)
AT (1) ATE149090T1 (no)
AU (1) AU1798192A (no)
CA (1) CA2110161C (no)
DE (1) DE69217658T2 (no)
EE (1) EE03053B1 (no)
FI (1) FI104948B (no)
GB (2) GB9111732D0 (no)
IE (1) IE67168B1 (no)
LT (1) LT3130B (no)
LV (1) LV10047B (no)
NO (1) NO303818B1 (no)
NZ (1) NZ242717A (no)
WO (1) WO1992021338A1 (no)
ZA (1) ZA923395B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5883115A (en) * 1992-11-09 1999-03-16 Pharmetrix Division Technical Chemicals & Products, Inc. Transdermal delivery of the eutomer of a chiral drug
GB2290964A (en) * 1994-07-08 1996-01-17 Arto Olavi Urtti Transdermal drug delivery system
GB9521680D0 (en) * 1995-10-23 1996-01-03 Orion Yhtymo Oy New use of imidazole derivatives
US5730721A (en) 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
GB9614098D0 (en) 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
IT1290255B1 (it) * 1997-02-05 1998-10-22 Wallcovering Pubblicita S R L Supporto sagomato aderente all'epidermide per la cessione di sostanze cosmetiche o farmacologiche e metodo per la sua fabbricazione
DE19936395C2 (de) 1999-08-03 2002-07-18 Antonia Buntz Kosmetikpflaster und Verfahren zum Anheben der weiblichen Brust mittels eines solchen Kosmetikpflasters und seine Verwendung
US6682757B1 (en) 2000-11-16 2004-01-27 Euro-Celtique, S.A. Titratable dosage transdermal delivery system
US7795263B2 (en) * 2008-07-08 2010-09-14 Wildlife Laboratories, Inc. Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
EP3305281A1 (en) * 2009-05-15 2018-04-11 Recro Pharma, Inc. Sublingual dexmedetomidine compositions and methods of use thereof
EP2521544A4 (en) * 2010-01-08 2013-08-21 Recro Pharma Inc TOPICAL TRANSDERMAL DEXMEDETOMIDINE COMPOSITIONS AND METHOD FOR THEIR USE
US20120202863A1 (en) * 2011-02-03 2012-08-09 Gerald Horn Compositions and methods for treatment of glaucoma
CA2858721C (en) 2011-12-11 2021-03-16 Recro Pharma, Inc. Intranasal dexmedetomidine compositions and methods of use thereof
EP3054934B1 (en) * 2013-10-07 2024-05-22 Teikoku Pharma USA, Inc. Methods and compositions for treating withdrawal syndromes using non-sedative dexmedetomidine transdermal compositions
RU2648449C2 (ru) * 2013-10-07 2018-03-26 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Способы и композиции для трансдермальной доставки неседативного количества дексмедетомидина
RU2018105761A (ru) * 2013-10-07 2019-02-26 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Устройства для трансдермальной доставки дексмедетомидина и способы их применения
TWI709417B (zh) * 2013-10-07 2020-11-11 美商帝國製藥美國股份有限公司 使用右美托咪啶經皮組成物用於治療注意力不足過動症、焦慮及失眠的方法及組成物
CN110604728A (zh) * 2013-10-07 2019-12-24 帝国制药美国公司 用于管理疼痛的包含右旋美托咪啶经皮组合物的方法及组合物
EP3087985B1 (en) 2013-12-18 2018-10-17 Maruishi Pharmaceutical Co., Ltd. Hydrous adhesive patch
KR20210113439A (ko) 2016-10-31 2021-09-15 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 전달 장치를 이용한 통증을 관리하는 방법
CN111346072B (zh) * 2018-12-21 2022-05-27 宜昌人福药业有限责任公司 一种透皮给药的药物组合物及其制备方法
WO2020222188A1 (en) 2019-05-01 2020-11-05 Clexio Biosciences Ltd. Methods of treating pruritus
WO2020222192A1 (en) 2019-05-01 2020-11-05 Clexio Biosciences Ltd. Methods of treating pruritus
TWI772807B (zh) 2019-05-27 2022-08-01 日商救急藥品工業股份有限公司 外用製劑

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
FI864570A0 (fi) * 1986-11-11 1986-11-11 Farmos Oy Terapeutiskt anvaendbar foerening.
GB2206880B (en) * 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative
GB2215206B (en) * 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
US5217718A (en) * 1989-08-18 1993-06-08 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
US5304569A (en) * 1989-11-13 1994-04-19 Orion-Yhtyma Oy Compositions and their use in lowering intraocular pressure

Also Published As

Publication number Publication date
JPH06507888A (ja) 1994-09-08
EP0587819A1 (en) 1994-03-23
IE921937A1 (en) 1992-12-02
CA2110161A1 (en) 1992-12-10
DE69217658D1 (de) 1997-04-03
FI935351A0 (fi) 1993-11-30
WO1992021338A1 (en) 1992-12-10
EE03053B1 (et) 1997-12-15
US5438067A (en) 1995-08-01
LV10047A (lv) 1994-05-10
IE67168B1 (en) 1996-03-06
GB9111732D0 (en) 1991-07-24
NO303818B1 (no) 1998-09-07
GB2256367B (en) 1995-03-15
LV10047B (en) 1995-02-20
FI104948B (fi) 2000-05-15
NZ242717A (en) 1994-03-25
LT3130B (en) 1994-12-25
EP0587819B1 (en) 1997-02-26
GB2256367A (en) 1992-12-09
DE69217658T2 (de) 1997-07-03
ATE149090T1 (de) 1997-03-15
ZA923395B (en) 1993-03-31
JP3483881B2 (ja) 2004-01-06
NO934323D0 (no) 1993-11-29
GB9211033D0 (en) 1992-07-08
JP2003327531A (ja) 2003-11-19
AU1798192A (en) 1993-01-08
LTIP112A (en) 1994-07-15
FI935351L (fi) 1993-11-30
CA2110161C (en) 2004-08-03

Similar Documents

Publication Publication Date Title
NO934323D0 (no) Medetomidin-preparater for transdermal administrasjon
ATE216240T1 (de) Transdermales therapeutisches system mit galanthamin als wirksamen bestandteil
DK581685A (da) Transderimalt system for timolol-indgift
ATE5563T1 (de) Therapeutisches system zum zufuehren von arzneimitteln zur haut.
CA2064687A1 (en) Method and device for administering dexmedetomidine transdermaly
NO993385L (no) Transdermalt terapeutisk system for avgivelse av hormoner
NO952908L (no) Nitroglycerolholdig plaster, fremgangsmåte for fremstilling, samt anvendelse av plasteret
FI952269A0 (fi) Ihonläpäisevä terapeuttinen järjestelmä fysostigmiinin antamiseen iholle ja menetelmä järjestelmän valmistamiseksi